birth has been examined using experimental models. [8] [9] [10] Infection and/or inflammation of the fetal membranes (chorioamnionitis) is an important risk factor, 11 complicating 40%-70% of spontaneous premature births. 12 A number of pro-inflammatory cytokines have been associated with chorioamnionitis and preterm birth, such as IL-1β, IL-6, and TNFα. 13 IL-1β, in particular, is an important mediator, 11, [14] [15] [16] and elevated inflammasome activity has been detected in fetal membranes from patients with preterm birth and acute histologic chorioamnionitis. 17 Studies suggest that MgSO 4 has anti-inflammatory properties. In pregnant rats, MgSO 4 prevented bacterial lipopolysaccharide (LPS)-induced inflammation in the placenta, amniotic fluid, fetal brain, and maternal and fetal circulation. 18, 19 In human placental perfusion studies, MgSO 4 reduced IL-1β, TNFα and IL-6 production. 20, 21 In vitro, MgSO 4 inhibited human term placental, decidual, and amniotic cell cytokine production in response to LPS. 19, 22 However, nothing is known about the effects on MgSO 4 on intact human chorioamniotic tissues. Therefore, using an established in vitro human fetal membrane (FM) explant system, [23] [24] [25] [26] we sought to: (i) characterize the effect of MgSO 4 on the FM response to bacterial infection using LPS as our model, and (ii) determine whether altering the time of MgSO 4 administration with respect to LPS exposure altered the response. Based on our recent study showing that viral infection augments LPS-induced FM inflammation, 26 we also examined the effect of MgSO 4 on FM responses to a polymicrobial infection using combination viral dsRNA (Poly[I:C]) and LPS as our model.
| MATERIAL S AND ME THODS

| Human FM collection and preparation
Human FMs were collected from planned uncomplicated term (37-41 weeks) cesarean deliveries without labor or known infection/ inflammation, as previously described. 24, 25 The study, including tissue collection, was approved by the University's Human Research Protection Program. After washing the FM with sterile PBS supplemented with penicillin (100 U/mL) and streptomycin (100 μg/ mL) (Gibco, Grand Island, NY, USA), blood clots were removed and explants where both the chorion and amnion were intact were obtained using a 6-mm biopsy punch. The FM explants were placed in 0.4-μm cell culture inserts (BD Falcon, Franklin Lakes, NJ, USA), with 500-μL Dulbecco's modified Eagle's medium (DMEM; Gibco)
supplemented with 10% fetal bovine serum (FBS; Hyclone, Logan, UT, USA), and these were placed in a 24-well plate containing 500 μL of the same DMEM media for 24 hours, as previously described.
23-25
The next day the media was removed and replaced with serum-free OptiMEM (Gibco). After 3 hours, treatments were initiated in serumfree OptiMEM.
| Human FM treatments
Fetal membrane explants were treated with or without LPS isolated 
| Caspase-1 activity assay
Caspase-1 activity was determined using the Caspase-Glo 1
Inflammasome assay (Promega, Madison, WI, USA). Briefly, 10 μg of the FM tissue lysates was incubated at room temperature in the dark for 1 hour with the caspase-1 substrate. Luminescence was measured using a TD-20/20 illuminometer (Turner Designs). The amount of luminescence detected as relative light units (RLU) was proportional to caspase-1 activity. All samples were assayed in triplicate.
| Statistical analysis
Each FM treatment experiment was performed in triplicate. All data are reported as mean ± SEM of pooled experiments. Statistical significance was set at P < .05 and determined using Prism Software (Graphpad, Inc; La Jolla, CA, USA). For normally distributed data, significance was determined using ANOVA or a paired t test. For data not normally distributed, significance was determined using a nonparametric test or the Wilcoxon matched-pairs signed rank test.
| RE SULTS
| MgSO 4 differentially modulates LPS-induced fetal membrane IL-1β secretion in a time-dependent manner
As previously reported, 
| MgSO 4 inhibits LPS-induced FM caspase-1 activity
Given the importance of IL-1β in FM responses to infection or infectious products, 24, [26] [27] [28] [29] and in infection-associated preterm birth, 11,14-16 the effect of MgSO4 on the mechanisms governing IL-1β production was examined. Fetal membrane IL-1β secretion in response to infectious stimuli is mediated by the inflammasome, 24, 26 where caspase-1 is a common marker of inflammasome activity. 30 As shown in Figure 3 , LPS treatment significantly increased FM caspase-1 activity by 2.7 ± 0.6-fold, and this was significantly in- 
| MgSO 4 inhibits FM IL-1β secretion in response to combination viral dsRNA and bacterial LPS
A viral infection may sensitize pregnancies to a subsequent bacterial challenge, leading to preterm birth. [8] [9] [10] Recent studies have highlighted a role for viral infections in modulating FM and placental responses to bacterial LPS. 8, 9, 26 Using this model, we sought to test the effect of MgSO 4 when given 1 hour post-LPS. As previously re- 
| D ISCUSS I ON
Magnesium sulfate is used in obstetrics for several indications: as a short-term tocolytic; to prevent maternal seizure; and to protect the preterm neonatal brain. [2] [3] [4] [5] [6] Magnesium deficiency is associated with increased levels of inflammatory cytokines such as IL-6, IL-1β and TNFα. 31, 32 However, despite MgSO 4 being studied as an inflammatory modulator for decades, 33, 34 its mechanism of action in obstetrical use is still unclear. As chorioamnionitis is a major risk factor for preterm birth, the objective of this study was to determine whether there was no effect on the LPS-induced inflammation. 18 In a similar model, placental IL-6, TNFα and MCP-1 levels were inhibited when MgSO 4 was given both prior to and after LPS. 19 In another study using isolated umbilical cord blood monocytes stimulated with LPS, supplementation of MgSO 4 15 minutes post-LPS exposure reduced
TNFα and IL-6 levels, while pre-exposure to MgSO 4 had no effect. 36 This in vitro study closely correlates with our inhibitory findings.
Furthermore, this study found that the time dependency of MgSO 4 's anti-inflammatory properties was directly associated with the rapid elevation in intracellular magnesium levels following supplementation, and inhibition of the NFκB pathway. 36, 37 This suggests that in human FM explants, when MgSO 4 is given 1 hour post-LPS there may be a similar rapid uptake and increase in intracellular magnesium content, leading to the observed inhibitory effects, and that based on our pre-treatment data this would not be sufficiently sustained over a 1-hour period in order to block the ability of LPS to initiate the inflammatory cascade.
As IL-1β is a potent pro-inflammatory cytokine and mediator of preterm birth, 11,14-16 we examined the mechanism by which MgSO 4 modulated this response. Caspase-1 is a common mediator of IL-1β
processing and subsequent secretion, typically activated by an inflammasome. 30 We found that MgSO 4 delivered 1-hour post-LPS treatment inhibited LPS-induced caspase-1 activity, suggesting this was one mechanism by which MgSO 4 reduced IL-1β production. In keeping with our observation that MgSO 4 can inhibit FM caspase-1 activation in response to LPS, a study using THP-1 cells reported that MgSO 4 can inhibit the NLRP3 inflammasome. 38 We previously reported that a viral infection of the FM can augment LPS-induced IL-1β production through activation of the NLPR3 inflammasome. 26 This combined with an increasing awareness of the potential impact viral infections may have on the maternal-fetal interface, and on pregnancy outcomes, 10, 39, 40 
ACK N OWLED G M ENTS
The authors would like to thank the staff of Yale-New Haven
Hospital's Labor and Birth, and the Yale University Reproductive
Sciences Biobank for their help with tissue collection. This study was supported by grant # R01AI121183 from the NIAID, NIH (to VMA).
CO N FLI C T O F I NTE R E S T
The authors have no conflict of interest.
O RCI D
Vikki M. Abrahams http://orcid.org/0000-0003-4995-1061
